The present disclosure relates generally to apparatuses useable to support or stabilize a medical device. Particular implementations relate to stabilizing devices having a passive locking mechanism and support tables useable therewith.
Prosthetic cardiac valves have been used for many years to treat cardiac valvular disorders. The native heart valves (such as the aortic, pulmonary, and mitral valves) serve critical functions in assuring the forward flow of an adequate supply of blood through the cardiovascular system. These heart valves can be rendered less effective by congenital, inflammatory, or infectious conditions. Such damage to the valves can result in serious cardiovascular compromise or death. For many years, the definitive treatment for such disorders was the surgical repair or replacement of the valve during open heart surgery, but such surgeries are prone to many complications. More recently, a transvascular technique has been developed for introducing and implanting a prosthetic heart valve using a flexible catheter in a manner that is less invasive than open heart surgery.
In this technique, a prosthetic valve is mounted in a crimped state on the end portion of a flexible catheter and advanced through a blood vessel of the patient until the prosthetic valve reaches the implantation site. The prosthetic valve at the catheter tip is then expanded to its functional size at the site of the defective native valve, such as by inflating a balloon on which the prosthetic valve is mounted. Alternatively, the prosthetic valve can have a resilient, self-expanding stent or frame that expands the prosthetic valve to its functional size when it is advanced from a delivery sheath at the distal end of the catheter.
Balloon-expandable prosthetic valves typically are preferred for replacing calcified native valves because the catheter balloon can apply sufficient expanding force to anchor the frame of the prosthetic valve to the surrounding calcified tissue. On the other hand, self-expanding prosthetic valves sometimes are preferred for replacing a defective, non-stenotic (non-calcified) native valve, although they also can be used to replace stenotic valves.
In addition to valve replacement, transcatheter techniques can be used to repair heart valves. In some cases, repair devices, such as leaflet clips, can be used to improve coaptation of valve leaflets. In other cases, transcatheter techniques can be used to surgically alter a heart valve, such as surgically removing a portion of the native heart valve leaflets to reduce excessive slack.
Because the catheter must be directed through a patient's vasculature, it typically is beneficial for the operator to be able to precisely control the operation of the catheter, including mechanisms that allow the catheter to be bent to assist in navigating the vasculature, and mechanisms that control deployment of the prosthetic valve. During a procedure, the operator can control the catheter using a handle, which can provide controls for extending, retracting, and bending the catheter, including during navigating the patient's vasculature to the delivery or repair site.
Transcatheter procedures can have a long duration, and it may be inconvenient for an operator to manually maintain the position of the catheter handle during the entire procedure. While it may be desirable to adjust the location of the catheter handle relative to the patient at some points during the procedure, at other times it can be desirable to maintain the position of the catheter handle relative to the patient, such as to maintain the depth of insertion of the catheter or the rotational position of the handle.
A catheter handle be secured to a table proximate the patient using a locking mechanism. Typically, locking mechanisms require a user to actively engage or disengage a locking device to secure or release the catheter handle from a stand or mount. For example, a clamping mechanism may be advanced, such as by advancing a clamp over a threaded shaft, to secure the clamp against the catheter handle and thus secure the catheter handle during a procedure. If it is desired to adjust the position of the catheter handle, the clamp can be released, the position of the catheter handle and/or mount adjusted, and the clamp re-secured. However, these processes can be time consuming and inconvenient.
An exemplary stabilizing apparatus for a medical device includes a housing having an aperture to receive the medical device. An engagement member is disposed in the housing. A biasing element urges the engagement member against a surface of the medical device, when the medical device is placed in the housing.
In certain exemplary embodiments, the aperture is positioned at an upper portion of the housing. In certain exemplary embodiments, the aperture is positioned at a lower portion of the housing. In certain exemplary embodiments, the aperture is positioned at a side portion of the housing.
In certain exemplary embodiments, the stabilizing apparatus further includes a door connected to the housing. The door has a first and second position. The door covers the aperture and passively engages the housing when the door is in the second position. In certain exemplary embodiments, the door is slideably adjustable from the first position to the second position. In certain exemplary embodiments, the door is pivotally adjustable from the first position to the second position.
In certain exemplary embodiments, the stabilizing apparatus passively clamps the medical device by releasing the engagement member. In certain exemplary embodiments, the biasing element is positioned below the medical device. In certain exemplary embodiments, the biasing element is positioned above the medical device. In certain exemplary embodiments, the biasing element is positioned to one side of the medical device. In certain exemplary embodiments, the housing is adjustable in height.
Various features as described elsewhere in this disclosure can be included in the examples summarized here and various methods and steps for using the examples and features can be used, including as described elsewhere herein. Any given embodiment of the present disclosure need not provide all features noted above, nor must it solve all problems or address all issues in the prior art noted above.
Further understanding of the nature and advantages of the disclosed inventions can be obtained from the following description and claims, particularly when considered in conjunction with the accompanying drawings in which like parts bear like reference numerals.
To further clarify various aspects of embodiments of the present disclosure, a more particular description of the certain embodiments will be made by reference to various aspects of the appended drawings. It is appreciated that these drawings depict only typical embodiments of the present disclosure and are therefore not to be considered limiting of the scope of the disclosure. Moreover, while the figures may be drawn to scale for some embodiments, the figures are not necessarily drawn to scale for all embodiments. Embodiments of the present disclosure will be described and explained with additional specificity and detail through the use of the accompanying drawings.
The present disclosure provides examples of stabilizing units for a medical device. The stabilizing unit can comprise a passive locking mechanism, whereby the locking mechanism engages the medical device when not being actively disengaged by a physician. The present disclosure also provides support tables useable with one or more stabilizing units, including support tables constructible from medical device packaging.
Referring first to
An engagement member 16 or engagement means engages at least one surface of the medical device. A variety of different engagement means are disclosed by the present application. For example,
In
In
The engagement member 16 can take a wide variety of different forms. For example, the engagement member can be flat as illustrated by
In the embodiments illustrated by
In the embodiments illustrated by
In the embodiments illustrated by
In the embodiment illustrated by
In the embodiment illustrated by
In the embodiment illustrated by
In the embodiment illustrated by
Referring to
The catheter 103 can be used for delivering any of various types of implantable medical devices into a patient's body, including, without limitation, prosthetic valves (e.g., prosthetic heart valves), stents, stent-grafts, and various types of leaflet or valve repair devices, such as annuloplasty devices, leaflet clips, and the like. In some implementations, the medical device 102 may comprise an assembly comprised of multiple catheters that are insertable into a patient's body. The handle of each catheter can be mounted on a separate stabilizing unit 106, with all stabilizing units 106 supported on the same platform, or on separate platforms.
The table 108 can comprise a generally horizontal portion 109 and a plurality of support members 119. The horizontal portion can define a generally planar mounting surface 110 onto which the stabilizing unit 106 can be placed or mounted. The table 108 can have vertical sides 112 extending upwardly from the longitudinal edges of the horizontal portion 109. The sides 112 can define laterally inwardly extending lips 114 that can define mounting ridges to which the stabilizing unit 106 can be secured, as further described below.
The table 108 can comprise a semi-circular cutout section 118 at a longitudinal end portion of the horizontal portion 109. The cutout section 118 can facilitate operator access to the stabilizing unit 106, including the handle 104 of the catheter 103 secured therein. In other cases, the cutout section 118 can have a different shape, can be located within another portion of the table 108, or can be omitted. Although the table 108 is shown with a rectangular mounting surface 110, the mounting surface can have other shapes, including square, triangular, round, or elliptical shapes.
The plurality of support members 119 can each comprise a vertical component or leg 120 and a horizontal component or foot 124. Each leg 120 can extend downwardly from (such as abutting), and orthogonally to, a lower surface of the horizontal portion 109. The horizontal portion 109 can comprise threaded mounting apertures 122 that receive axially-extending threaded upper end portions (not shown) of the legs 120. A foot 124 can extend laterally from a bottom axial end of each leg 120.
Each leg 120 can comprise an externally threaded lower end portion that threadably engages a mating threaded aperture of its respective foot 124. Alternatively, the feet 124 can comprise axially extending threaded posts that extend into internally threaded apertures in the bottom axial ends of the legs 120. In yet further implementations, the feet 124 and the legs 120 can be securely coupled in another manner, such as by welding or the use of a suitable adhesive, fasteners (e.g., screws), or the support members 119 can be of unitary construction (e.g., the legs 120 and feet 124 molded as a unit). The feet 124 can be dimensioned and shaped such that they can be placed on a surface, such as an operating table, to provide resistance against tipping or torsional movement of the table 108, thus maintaining the mounting surface 110 in an at least substantially horizontal position.
In particular examples, components of the table 108 can be dimensioned and positioned with respect to one another such that the table may be placed between the legs of a patient lying on an operating table. For example, the legs 120 can be placed between the patient's legs, with the feet 124 resting on an operating table. The patient's legs can be placed over the feet 124 to help maintain the table 108 in a desired position, including resisting translational and torsional movement. The feet 124 can have a width that is sufficiently small such that placing the legs of the patient over the feet does not cause the patient discomfort. The feet 124 can have a length sufficiently long to extend underneath the legs of a patient such that the patient's legs can rest on top of the feet and help secure the table 108 in place relative to the patient during a procedure. If desired, the table 108 can be further anchored in place against the patient and/or the operating table, such as by using fasteners, adhesive tape, sutures, or other fastening means.
With reference to
The base member 128 can comprise a broad, U-shaped body comprising a plurality of longitudinally extending arms 144, and a laterally extending slot 152. The body of the base member 128 can have an at least substantially planar bottom surface adapted to be mounted on the mounting surface 110 of the table 108. The arms 144 can comprise longitudinally extending cutout sections 146. In at least some cases, the cutout sections 146 can extend through the upper and lower surfaces of the arms 144 (i.e., the cutout sections extend the entire height of the arms 144). In other cases, a portion of the bottom of the base 128 can extend beneath the cutout sections 146, such that the cutout sections 146 do not extend through the bottom surfaces of the arms 144 (i.e., the cutout sections are recessed portions in the upper surfaces of the arms 144). The cutout sections 146 can be used to help secure the base member 128 to the table 108.
For example, as shown in
In other embodiments, rather than using a separate clamp 148, the stabilizing unit 106 can incorporate a clamping mechanism. For instance, an outer, lateral surface of an arm 144 can incorporate a clamp that can be secured to a lateral side 112 of the table 108.
As illustrated in
In yet other embodiments, a clamp need not be used with the stabilizing unit 106. If desired, a bottom surface of the stabilizing unit 106 can be formed from a material with a large coefficient of friction, or pads of a material with a large coefficient of friction can be attached (such as being adhered) to a bottom surface of the stabilizer unit. The stabilizing unit 106 can be constructed from a material having a weight sufficient to help retain the stabilizing unit at a desired position on the table 108.
As best shown in
The lower housing portion 130 can comprise a lower portion 158, an upper mounting section 166, and a plurality of vertical post members 168. As best shown in
As further shown in
The stabilizing fork 136 can comprise an enlarged lower portion 174 dimensioned to fit over the mounting section 166 of the lower housing portion 130. For example, the lower portion 174 can extend around the mounting section 166, abutting the upper surface of the lower portion 158 of the lower housing, when the stabilizing fork 136 is depressed downwardly by a user wishing to adjust the position of a medical device secured thereby, as further described below In at least some aspects, the height of the mounting section 166 and the height of the lower portion 174 can be selected based on the desired degree of travel of the stabilizing fork 136 between its compressed and released positions. That is, the heights can correspond to the degree of travel of the stabilizing fork.
The stabilizing fork 136 can comprise arms 176 separated by the U-shaped slot 140. The base of the slot 140 can comprise a plurality of ridges 178 extending transversely between the vertical faces of the stabilizing fork 136. The ridges 178 can define scalloped mounting recesses 180 that can be configured to engage surface features of a medical device, such as the handle 104 of the catheter 103, to help secure the handle against rotational movement relative to the stabilizing fork 136.
The upper housing portion 134 can comprise longitudinally extending U-shaped slots 142 formed in the vertical side walls 183 of the upper housing portion and a laterally extending inverted T-shaped slot 184 formed in the upper end portion of the upper housing portion. The U-shaped slots 142 can have at least approximately the same width as the U-shaped slot 140 of the stabilizing fork 136. The inverted. T-shaped slot 184 can have an upper portion 192 (the stem of the T) having a width smaller than the width of a lower portion 191 (the crossbar of the T). The side walls 183, the sides of the slot 184 and the upper ends 182 of the upper housing portion 134, can be spaced apart to provide a vertical aperture 186 between the faces through which the arms 176 of the stabilizing fork 136 can extend.
The retaining arm 138 can comprise guide rails 188, the slot 196, and a stop 198. The slot 184 can be configured to receive lower portions 194 of the guide rails 188 of the retaining arm 138. The lower portions 194 are configured to extend into recesses of the slot 194 formed by the lower portion 191 of the slot 184. Upper portion 195 of the guide rails 188 are configured to abut the upper ends 182 of the upper housing portion 134. The upper 195 and lower 194 portions of the guide rails 182 can have a larger width than an intermediate portion of the guiderails, forming an outwardly facing groove 197.
The guide rails 188 can be spaced apart to provide an aperture 190 through which the upper end portions of the arms 176 of the stabilizing fork 136 can extend. An upper portion 192 of the slot 184 can have a smaller width than the lower portion 194 and upper portion 195 of the guide rails 188, thus preventing the guide rails from being removed from the slot by moving them upwardly, away from the upper housing portion 134. That is, the groove 197 can be slid over the upper portion 192 of the slot 184.
The stop 198 can extend downwardly from a bottom surface of the retaining arm. The stop 198 can be configured to engage a lateral side of the upper housing portion 134, limiting movement of the retaining arm 138 relative to the upper housing portion.
The guide rails 188 can define the semi-circular (or, in some cases, U-shaped) slots 196. The slots 196 can comprise ridges 178 and mounting recesses 180 like the slot 140 of the stabilizing fork 136. The slots 196 of the retaining arm 138 can cooperate with the slots 142 of the upper housing portion 134 and the slot 140 of the stabilizing fork 136 to form a yoke useable to secure a medical device placed therethrough.
In use, the support members 119 can be placed on an operating table, with the legs 120 between a patient's legs. The patient's legs can be placed over the feet 124 to help secure the table 108. The stabilizing unit 106 can be placed on the support surface 110 of the table 108. The stabilizing unit 106 can be moved to a desired longitudinal position on the support surface 110 and moved laterally to abut a lateral side 112 of the table 108. The stabilizing unit 106 may then be secured in position, such as by attaching the clamp 148 about the side 150 of the outer arm 144 of the base 128 and the outer surface of the lateral side 112. The side 150 of the arm 144 can be positioned beneath the lip 114 such that the inner edge of the recess 146 and the outer edge of the lip are flush, which can help provide a uniform clamping surface for the clamp 148. Although one clamp 148 is shown in
The retaining arm 138 of the stabilizing unit 106 can be removed from the stabilizing unit, or retracted from the slot 184 of the upper housing portion 134 so as to allow the handle 104 of the catheter 103 to be placed in the slots 140 and 142. While the handle 104 is being placed in the slots 140 and 142, the stabilizing fork 136 can be manually depressed toward the lower housing portion 130 against the biasing force of the biasing members to move the slot 140 lower relative to upper housing portion 134. With the handle 104 inserted within the slots 140 and 142, the retaining arm 138 can be slid toward the upper housing portion 134 to place the slots 196 over the slots 140 and 142. Manual pressure on the stabilizing fork 136 can then be released, which allows the biasing members 170 to push the lower surface of the slot 140 against a lower circumferential surface of the handle 104 of the catheter 103 and an upper circumferential surface of the handle 104 against the slots 196. The upwardly directed force of the biasing members 170 holds the handle of the catheter between the stabilizing fork and the stabilizing arm and resists against inadvertent axial and rotational movement of the catheter relative to the stabilizing unit. The ridges 178 and mounting recesses 180 can mate with corresponding features on the handle 104 to help secure the handle against rotational movement within the slots 140 and 196.
If an operator desires to adjust the position of the medical device 102 (the axial and/or rotation position of the medical device), the operator can manually depress the stabilizing fork 136 to move the slot 140 out of engagement with the handle 104. While maintaining the compressive force against the stabilizing fork 136, the operator can adjust the position of the catheter handle 104, including rotating it or moving it distally or proximally relative to a patient. When the operator is satisfied with the position of the medical device 102, the operator can remove the compressive force from the stabilizing fork 136, whereby the biasing members 170 will again urge the stabilizing fork 136 upwardly such that the slot 140 abuts the handle 104, securing the handle between the slot 140 and the slots 196 of the retaining arm 138. The operator can repeat this adjustment as desired during a medical procedure.
Although one stabilizing unit 106 is shown placed on the table 108, plural stabilizing units 106 can be placed on the same table 108 and used to secure respective medical devices during a medical procedure. For example, if the medical assembly includes multiple catheters inserted coaxially through one another, the stabilizing units 106 can be placed one behind the other along the length of the platform 108, with the handle of each catheter mounted in one of the stabilizing units. In another example, if the medical assembly includes multiple catheters placed side-by-side, the stabilizing units 106 can be placed side-by-side or laterally spaced across with the width of the platform 108, with the handle of each catheter mounted in one of the stabilizing units.
The housing 210 can define vertical, U-shaped slots 214 formed in the front and rear vertical side walls of the housing. The U-shaped slots 214 can be aligned with a U-shaped slot 218 formed in the stabilizing fork 222. The U-shaped slot 218 can define vertically extending arms 226 of the stabilizing fork 222, which can extend upwardly through the retaining arm 230. The stabilizing fork 222 can be mounted in a space between the opposing front and rear vertical side walls of the housing 210.
The pivotable retaining arm 230 can comprise a mounting end portion 232 and an actuating tab 234. The mounting end portion 232 can be hingeably connected to a mounting projection 236 extending vertically from a lateral side of the upper end of the housing 210. For example, the mounting end portion 232 can be connected to the mounting projection 236 using a pin 238 or similar coupling mechanism inserted through apertures 240 formed in the mounting end portion 232 lone of which is shown in
The actuating tab 234 can define a tongue 242 inwardly extending toward the lower end of the housing 210 from a lower surface of the actuating tab. The upper end portion of the housing 210 can define a groove 250 for receiving the tongue 242, allowing the retaining arm 230 to be releasably secured to the housing 210.
The lower longitudinal surface of the retaining arm 230 can define a semi-circular (or, in some cases, U-shaped) slots 258. The slots 258 of the retaining arm 230, the slots 214 of the housing 210, and the slot 218 of the stabilizing fork 222 can cooperate to form a yoke that can abut a medical device extending therethrough. The stabilizing fork 222 can be biased towards the retaining arm 230, such as using springs or other biasing members, which can be placed in contact with the stabilizing fork in a similar manner as the biasing devices 170 and the stabilizing fork 136 of
The stabilizing unit 200 can be used in a similar manner as the stabilizing unit 106. When a medical device is to be inserted into the unit 200, the tongue 242 can be removed from the groove 250 by pulling the actuating tab 234 and pivoting the retaining arm 230 away from the housing 210. The stabilizing fork 222 can be manually depressed, and the medical device can be inserted within the slots 214, 218. The retaining arm 230 can then be pivoted toward the housing 210 and the tongue 242 secured within the groove 250. The compressive force on the stabilizing fork 222 can be removed, allowing the stabilizing fork to move upwardly towards the retaining arm 230, and urging the slot 218 against the lower surface of the medical device, and in turn pushing the medical device against the bottom of the slots 258. The position of the medical device can be adjusted by again manually depressing the stabilizing fork 222 such that the slot 218 is moved out of engagement with the medical device.
Components of a stabilizing system, such as the medical device 102, the stabilizing unit 106 (or the unit 200), and the table 108, are typically shipped to a location (such as a clinic or hospital) where a medical procedure is to be performed. In at least some cases, the packaging used to ship or store system components can be used to construct all or a portion of other system components. In particular, packaging can be used to construct all or a portion of a table on which a stabilizing unit can be placed.
The support members 312 can be pivotable relative to the sheet 300 and can each have an upper leg 320 and a lower leg 326 connected to each other by a connecting post 322. The upper leg 320 of each support member 312 can be secured to a bottom surface 316 of the packing sheet 300 by the retaining members 324, which can be secured to the bottom surface of the packaging sheet, such as with a suitable adhesive, by welding, and/or fasteners. Although not shown, in a shipping and storage configuration 328, the lower leg 326 of one or both of the support members 312 can be disposed over a portion of the recess 308, thus helping secure the handle 304 of the medical device within the recess and protecting it from damage.
With reference to a use configuration 332, when the medical device 304 is to be used, or the packaging sheet 300 is otherwise desired to be converted to a table for use in a medical procedure, the support members 312 can be pivoted by rotating the lower legs 326 outwardly such that the support members 312 extend vertically from the bottom surface 316 of the packaging sheet 300.
The packaging sheet 300 can be turned over and the lower legs 326 placed on a supportive surface, such as an operating table (not shown) to provide an unfolded and operative configuration 340, as shown in
The flap 408, which can be generally rectangular, can extend from the side of a longitudinal end portion of the base 404. The flap 408 can be used, for example, to help protect components (such as a prosthetic valve, a delivery assembly for a prosthetic valve, a stabilizing unit, or components thereof) from damage during transit. In some cases, the flap 408 can be removed prior to constructing the table 406 from the packaging sheet 400. The flap 408 can be cut or torn off, for example, and the flap can comprise features to assist in its removal. A side 412 of the flap 408 extending from the base 404 can comprise perforations, scoring, or creases to assist in removing the flap from the base. In other cases, the flap 408 can be folded behind the base 404 and used to help provide structural support to the table 406, such as by making a span of the table 406 more rigid.
The longitudinal ridges 416 can extend vertically from, and orthogonally to, a horizontal portion 415 of the base 404. The ridges 416 can be formed by folding the sides of the base 404. The base 404 can comprise creases or other features to aid in forming the ridges 416. In other cases, the packaging sheet 400 can comprise preformed ridges 416, such as being molded to comprise both the horizontal portion 415 and the ridges.
The retaining members 422, such as flaps, loops, straps, and notches, can be formed from, or coupled to, the base 404. The retaining members 422 can be used to help secure and organize components of a prosthetic valve, delivery assembly, or stabilizing unit during transit. For instance, retaining members 422 (e.g. loops) can be used to secure a tube 432. The tube 432 can be used to house a prosthetic valve within a storage tube (not shown). Other retaining members 422 (e.g., straps and notches) can be used to secure components of a delivery assembly, such as a guide sheath (e.g., the guide sheath 304 of
The base 404 can be folded at the fold points 436, which can extend laterally across the base, to construct the table 406. The fold points 436 can be creased, scored, or perforated to assist a user in identifying the correct fold location, folding the base 404 in the correct direction, and allowing the base to fold more easily about a fold point. In the illustrated embodiment, the base 404 comprises three fold points 432. The fold points 436 can divide the base into a plurality of segments 442, 444, 446, and 448. Depending on how the table 406 is constructed, more or fewer fold points 436 can be included or used. For example, the base 404 can produce a U-shaped table using two fold points.
In some configurations of a table 406, one of the segments may need to pass through, or be secured to, another segment. For example, with additional reference to
As shown best in
In another aspect, rather than folding the segment 446 to produce the tabs 460, strips of material (e.g., the material between the fold lines 464) can be removed from the segment 448 to form the tabs. In order to facilitate the removal of the strips of material, the fold lines 464 can be scored or perforated.
The segment 442 can define a flap 476. The sides of the flap 476 can be creased, scored, or perforated to help a user fold the flap out (e.g., by rotating the flap about a lateral axis of the base 404) during table assembly. The flap 476 can be used to help secure a stabilizing unit to the table 406 during a medical procedure.
Segment 448 can intersect segment 444 at least approximately at the longitudinal midpoint of segment 444. The tabs 460 of segment 448 are shown inserted through the slots 456 of segment 444 and the slots 452 of segment 442. The ridges 416 are shown as downwardly folded after passing upwardly through the slots 456. The downwardly folded ridges 416 can provide widened portions 472 that can help prevent the tabs 460 from sliding back through the slots 456, helping to make the table 406 more rigid and secure. Similarly, the widened portions 472 proximate the slots 452 can help prevent the tabs 460 from sliding back through the slots.
The flap 476 is shown as extending upwardly from the surface of the segment 442. A stabilizing unit can be placed on the surface of the segment 442, which provides a support surface, and secured to the flap 476. For example, a stabilizing unit can be secured to the flap 476, in an analogous manner to how the stabilizing unit 106 of
The use of packaging to produce tables or platforms for a medical device (such as a stabilizing unit) can provide a number of advantages. For instance, it can be less wasteful of material, and less expensive, than providing a table as a separate, discrete component. In addition, the table, at least in part because of its inexpensiveness, can be a single-use, disposable component. Although a single table is shown, packaging can be provided to provide multiple tables, one or more of which can be used in a medical procedure.
The table 800 can include a plurality of coupling members 822 (one of which is visible in
In some implementations, the receptacles 836 can be selectively detached from the coupling members 822, and the coupling members can be maintained at a fixed position with respect to the lateral sides 814 (e.g., the coupling members do not rotate), or the coupling members can be maintainable at a fixed position they can be locked at a desired position). Thus, the height and angle of the elongate surface 810 of the table 800 can be adjusted by manipulating the position of the support members 818 relative to the lateral surface, and then inserting the receptacles 836 over their respective coupling member 822 when the lateral surface is at a desired position. The height of the elongate surface 810 can be adjusted, but maintained in a horizontal position, by rotating the support members 818 relative to the elongate surface, but maintaining the support members at the same rotational position. If the table 800 is desired to be maintained at an angled, or slanted, position, one of the support members 818 can be rotated to a different degree than the other support member.
An arm 852 can extend from a lower end 848 of each support member 818. A foot 856 can be disposed about each of the arms 852, such as by inserting a respective arm through an opening 860 axially formed in the arm. The feet 856 can be rotatable relative to the arms 852, such that the feet can rest on a surface, such as a horizontal surface, even when the support members 818 are not maintained in a vertical orientation. The feet 856 can be formed from a resilient material, such that a patient may comfortably lay on the feet, helping secure the table 800 in a desired position.
Various modifications can be made to the table 800. For instance, one or both of the coupling members 822 and the receptacles 836 can be rotatable. When one or both of the coupling members 822 and the receptacles 836 are rotatable, the components may be secured to one another, or be an integral component, if desired. A locking/release mechanism, such as a spring loaded pawl, can be used to engage teeth associated with the support members 818 in order to maintain each support member at a desired position. In some embodiments, the upper end portion of each support member 818 can be pivotably connected to the table 800, such as via a pivot pin extending through the upper end portion of each support member 818 and an adjacent portion of the table.
General Considerations
For purposes of this description, certain aspects, advantages, and novel features of the embodiments of this disclosure are described herein. The disclosed methods, devices, and systems should not be construed as limiting in any way. Instead, the present disclosure is directed toward all novel and nonobvious features and aspects of the various disclosed embodiments, alone and in various combinations and sub-combinations with one another. The methods, devices, and systems are not limited to any specific aspect or feature or combination thereof, nor do the disclosed embodiments require that any one or more specific advantages be present or problems be solved.
Features and characteristics described in conjunction with a particular aspect, embodiment or example of the invention are to be understood to be applicable to any other aspect, embodiment or example described herein unless incompatible therewith. All of the features disclosed in this specification (including any accompanying claims, abstract and drawings), and/or all of the steps of any method or process so disclosed, may be combined in any combination, except combinations where at least some of such features and/or steps are mutually exclusive. The invention is not restricted to the details of any foregoing embodiments. The invention extends to any novel one, or any novel combination, of the features disclosed in this specification (including any accompanying claims, abstract and drawings), or to any novel one, or any novel combination, of the steps of any method or process so disclosed.
Although the operations of some of the disclosed methods are described in a particular, sequential order for convenient presentation, it should be understood that this manner of description encompasses rearrangement, unless a particular ordering is required by specific language. For example, operations described sequentially may in some cases be rearranged or performed concurrently. Moreover, for the sake of simplicity, the attached figures may not show the various ways in which the disclosed methods can be used in conjunction with other methods. As used herein, the terms “a”, “an” and “at least one” encompass one or more of the specified element. That is, if two of a particular element are present, one of these elements is also present and thus “an” element is present. The terms “a plurality of” and “plural” mean two or more of the specified element.
As used herein, the term “and/or” used between the last two of a list of elements means any one or more of the listed elements. For example, the phrase “A, B, and/or C” means “A,” “B,” “C,” “A and B,” “A and C,” “B and C” or “A, B and C.”
As used herein, the term “coupled” generally means physically coupled or linked and does not exclude the presence of intermediate elements between the coupled items absent specific contrary language.
In view of the many possible embodiments to which the principles of the disclosed invention may be applied, it should be recognized that the illustrated embodiments are only preferred examples of the invention and should not be taken as limiting the scope of the invention. All combinations or subcombinations of features of the foregoing exemplary embodiments are contemplated by this application, e.g., features of one embodiment can be incorporated into other embodiments. The scope of the invention is defined by the following claims. We therefore claim as our invention all that comes within the scope and spirit of these claims.
Number | Name | Date | Kind |
---|---|---|---|
3874388 | King et al. | Apr 1975 | A |
4340091 | Skelton et al. | Jul 1982 | A |
4506669 | Blake, III | Mar 1985 | A |
4533179 | Nichols et al. | Aug 1985 | A |
4590937 | Deniega | May 1986 | A |
4693248 | Failla | Sep 1987 | A |
4803983 | Siegel | Feb 1989 | A |
4951576 | Cobos et al. | Aug 1990 | A |
5125895 | Buchbinder et al. | Jun 1992 | A |
5171252 | Friedland | Dec 1992 | A |
5195962 | Martin et al. | Mar 1993 | A |
5246109 | Markle et al. | Sep 1993 | A |
5292326 | Green et al. | Mar 1994 | A |
5314411 | Bierman et al. | May 1994 | A |
5327905 | Avitall | Jul 1994 | A |
5359741 | Lang | Nov 1994 | A |
5363861 | Edwards et al. | Nov 1994 | A |
5370685 | Stevens | Dec 1994 | A |
5389077 | Melinyshyn et al. | Feb 1995 | A |
5411552 | Andersen et al. | May 1995 | A |
5450860 | O'Connor | Sep 1995 | A |
5456674 | Bos et al. | Oct 1995 | A |
5474057 | Makower et al. | Dec 1995 | A |
5478353 | Yoon | Dec 1995 | A |
5487746 | Yu et al. | Jan 1996 | A |
5565004 | Christoudias | Oct 1996 | A |
5607462 | Imran | Mar 1997 | A |
5609598 | Laufer et al. | Mar 1997 | A |
5611794 | Sauer et al. | Mar 1997 | A |
5626607 | Malecki et al. | May 1997 | A |
5695504 | Gifford, III et al. | Dec 1997 | A |
5716417 | Girard et al. | Feb 1998 | A |
5727569 | Benetti et al. | Mar 1998 | A |
5741297 | Simon | Apr 1998 | A |
5782746 | Wright | Jul 1998 | A |
5797960 | Stevens et al. | Aug 1998 | A |
5836311 | Borst et al. | Nov 1998 | A |
5843076 | Webster, Jr. et al. | Dec 1998 | A |
5855590 | Malecki et al. | Jan 1999 | A |
5885271 | Hamilton et al. | Mar 1999 | A |
5888247 | Benetti | Mar 1999 | A |
5891017 | Swindle et al. | Apr 1999 | A |
5891112 | Samson | Apr 1999 | A |
5894843 | Benetti et al. | Apr 1999 | A |
5921979 | Kovac et al. | Jul 1999 | A |
5944738 | Amplatz et al. | Aug 1999 | A |
5957835 | Anderson et al. | Sep 1999 | A |
5972020 | Carpentier et al. | Oct 1999 | A |
5980534 | Gimpelson | Nov 1999 | A |
6004329 | Myers et al. | Dec 1999 | A |
6010531 | Donlon et al. | Jan 2000 | A |
6017358 | Yoon et al. | Jan 2000 | A |
6086600 | Kortenbach | Jul 2000 | A |
6120496 | Whayne et al. | Sep 2000 | A |
6132370 | Furnish et al. | Oct 2000 | A |
6162239 | Manhes | Dec 2000 | A |
6165183 | Kuehn et al. | Dec 2000 | A |
6182664 | Cosgrove | Feb 2001 | B1 |
6193732 | Frantzen et al. | Feb 2001 | B1 |
6193734 | Bolduc et al. | Feb 2001 | B1 |
6200315 | Gaiser et al. | Mar 2001 | B1 |
6241743 | Levin et al. | Jun 2001 | B1 |
6269819 | Oz et al. | Aug 2001 | B1 |
6269829 | Chen et al. | Aug 2001 | B1 |
6312447 | Grimes | Nov 2001 | B1 |
6461366 | Seguin | Oct 2002 | B1 |
6468285 | Hsu et al. | Oct 2002 | B1 |
6508806 | Hoste | Jan 2003 | B1 |
6508825 | Selmon et al. | Jan 2003 | B1 |
6530933 | Yeung et al. | Mar 2003 | B1 |
6537290 | Adams et al. | Mar 2003 | B2 |
6544215 | Bencini et al. | Apr 2003 | B1 |
6626930 | Allen et al. | Sep 2003 | B1 |
6629534 | St. Goar et al. | Oct 2003 | B1 |
6719767 | Kimblad | Apr 2004 | B1 |
6764510 | Vidlund et al. | Jul 2004 | B2 |
6770083 | Seguin | Aug 2004 | B2 |
6837867 | Kortelling | Jan 2005 | B2 |
6855137 | Bon | Feb 2005 | B2 |
6913614 | Marino et al. | Jul 2005 | B2 |
6939337 | Parker et al. | Sep 2005 | B2 |
6945956 | Waldhauser et al. | Sep 2005 | B2 |
7048754 | Martin et al. | May 2006 | B2 |
7101395 | Tremulis et al. | Sep 2006 | B2 |
7125421 | Tremulis et al. | Oct 2006 | B2 |
7288097 | Seguin | Oct 2007 | B2 |
7371210 | Brock et al. | May 2008 | B2 |
7464712 | Oz et al. | Dec 2008 | B2 |
7509959 | Oz et al. | Mar 2009 | B2 |
7569062 | Kuehn et al. | Aug 2009 | B1 |
7682369 | Seguin | Mar 2010 | B2 |
7731706 | Potter | Jun 2010 | B2 |
7744609 | Allen et al. | Jun 2010 | B2 |
7748389 | Salahieh et al. | Jul 2010 | B2 |
7753932 | Gingrich et al. | Jul 2010 | B2 |
7758596 | Oz et al. | Jul 2010 | B2 |
7776017 | Ponzi et al. | Aug 2010 | B2 |
7780723 | Taylor | Aug 2010 | B2 |
7803185 | Gabbay | Sep 2010 | B2 |
7824443 | Salahieh et al. | Nov 2010 | B2 |
7981123 | Seguin | Jul 2011 | B2 |
7988724 | Salahieh et al. | Aug 2011 | B2 |
8052750 | Tuval et al. | Nov 2011 | B2 |
8070805 | Vidlund et al. | Dec 2011 | B2 |
8096985 | Legaspi et al. | Jan 2012 | B2 |
8104149 | McGarity | Jan 2012 | B1 |
8133239 | Oz et al. | Mar 2012 | B2 |
8147542 | Maisano et al. | Apr 2012 | B2 |
8162898 | Wright | Apr 2012 | B1 |
8206437 | Bonhoeffer et al. | Jun 2012 | B2 |
8211064 | Sloan | Jul 2012 | B2 |
8216301 | Bonhoeffer et al. | Jul 2012 | B2 |
8277420 | Bierman et al. | Oct 2012 | B2 |
8303653 | Bonhoeffer et al. | Nov 2012 | B2 |
8313525 | Tuval et al. | Nov 2012 | B2 |
8348995 | Tuval et al. | Jan 2013 | B2 |
8348996 | Tuval et al. | Jan 2013 | B2 |
8414643 | Tuval et al. | Apr 2013 | B2 |
8425404 | Wilson et al. | Apr 2013 | B2 |
8449599 | Chau et al. | May 2013 | B2 |
8449606 | Eliasen et al. | May 2013 | B2 |
8460368 | Taylor et al. | Jun 2013 | B2 |
8470028 | Thornton et al. | Jun 2013 | B2 |
8480730 | Maurer et al. | Jul 2013 | B2 |
8540767 | Zhang | Sep 2013 | B2 |
8579965 | Bonhoeffer et al. | Nov 2013 | B2 |
8585756 | Bonhoeffer et al. | Nov 2013 | B2 |
8608705 | Peters et al. | Dec 2013 | B2 |
8652202 | Alon et al. | Feb 2014 | B2 |
8668733 | Haug et al. | Mar 2014 | B2 |
8721665 | Oz et al. | May 2014 | B2 |
8734400 | Ciccone | May 2014 | B2 |
8740918 | Seguin | Jun 2014 | B2 |
8771347 | DeBoer et al. | Jul 2014 | B2 |
8778017 | Eliasen et al. | Jul 2014 | B2 |
8827960 | Haak | Sep 2014 | B2 |
8834564 | Tuval et al. | Sep 2014 | B2 |
8840663 | Salahieh et al. | Sep 2014 | B2 |
8876894 | Tuval et al. | Nov 2014 | B2 |
8876895 | Tuval et al. | Nov 2014 | B2 |
8945177 | Dell et al. | Feb 2015 | B2 |
9034032 | McLean et al. | May 2015 | B2 |
9198757 | Schroeder et al. | Dec 2015 | B2 |
9220507 | Patel et al. | Dec 2015 | B1 |
9259317 | Wilson et al. | Feb 2016 | B2 |
9278193 | Haider et al. | Mar 2016 | B2 |
9282972 | Patel et al. | Mar 2016 | B1 |
9301834 | Tuval et al. | Apr 2016 | B2 |
9308360 | Bishop et al. | Apr 2016 | B2 |
9387071 | Tuval et al. | Jul 2016 | B2 |
9427327 | Parrish | Aug 2016 | B2 |
9439763 | Geist et al. | Sep 2016 | B2 |
9510837 | Seguin | Dec 2016 | B2 |
9510946 | Chau et al. | Dec 2016 | B2 |
9572660 | Braido et al. | Feb 2017 | B2 |
9642704 | Tuval et al. | May 2017 | B2 |
9700445 | Martin et al. | Jul 2017 | B2 |
9775963 | Miller | Oct 2017 | B2 |
D809139 | Marsot et al. | Jan 2018 | S |
9889002 | Bonhoeffer et al. | Feb 2018 | B2 |
9949824 | Bonhoeffer et al. | Apr 2018 | B2 |
10076327 | Ellis et al. | Sep 2018 | B2 |
10076415 | Metchik et al. | Sep 2018 | B1 |
10105221 | Siegel | Oct 2018 | B2 |
10105222 | Metchik et al. | Oct 2018 | B1 |
10111751 | Metchik et al. | Oct 2018 | B1 |
10123873 | Metchik et al. | Nov 2018 | B1 |
10130475 | Metchik et al. | Nov 2018 | B1 |
10136993 | Metchik et al. | Nov 2018 | B1 |
10159570 | Metchik et al. | Dec 2018 | B1 |
10226309 | Ho et al. | Mar 2019 | B2 |
10231837 | Metchik et al. | Mar 2019 | B1 |
10238493 | Metchik et al. | Mar 2019 | B1 |
10238494 | McNiven et al. | Mar 2019 | B2 |
10238495 | Marsot et al. | Mar 2019 | B2 |
10299924 | Kizuka | May 2019 | B2 |
10376673 | Van Hoven et al. | Aug 2019 | B2 |
20010005787 | Oz et al. | Jun 2001 | A1 |
20020013571 | Goldfarb et al. | Jan 2002 | A1 |
20020107531 | Schreck et al. | Aug 2002 | A1 |
20020173811 | Tu et al. | Nov 2002 | A1 |
20020183787 | Wahr et al. | Dec 2002 | A1 |
20030144573 | Heilman et al. | Jul 2003 | A1 |
20030187467 | Schreck | Oct 2003 | A1 |
20030208231 | Williamson et al. | Nov 2003 | A1 |
20040003819 | St. Goar et al. | Jan 2004 | A1 |
20040034365 | Lentz et al. | Feb 2004 | A1 |
20040044350 | Martin et al. | Mar 2004 | A1 |
20040044365 | Bachman | Mar 2004 | A1 |
20040049207 | Goldfarb et al. | Mar 2004 | A1 |
20040127981 | Randert et al. | Jul 2004 | A1 |
20040127982 | Machold et al. | Jul 2004 | A1 |
20040147943 | Kobayashi | Jul 2004 | A1 |
20040181206 | Chiu et al. | Sep 2004 | A1 |
20040181238 | Zarbatany et al. | Sep 2004 | A1 |
20040210307 | Khairkhahan | Oct 2004 | A1 |
20040220593 | Greenhalgh | Nov 2004 | A1 |
20040267089 | Otsuka et al. | Dec 2004 | A1 |
20050049618 | Masuda et al. | Mar 2005 | A1 |
20050137690 | Saiahieh et al. | Jun 2005 | A1 |
20050143767 | Kimura et al. | Jun 2005 | A1 |
20050165429 | Douglas et al. | Jul 2005 | A1 |
20050216039 | Lederman | Sep 2005 | A1 |
20050251183 | Buckman et al. | Nov 2005 | A1 |
20050288786 | Chanduszko | Dec 2005 | A1 |
20060020275 | Goldfarb et al. | Jan 2006 | A1 |
20060058738 | Ponzi | Mar 2006 | A1 |
20060089671 | Goldfarb et al. | Apr 2006 | A1 |
20060100649 | Hart | May 2006 | A1 |
20060122647 | Callaghan et al. | Jun 2006 | A1 |
20060142694 | Bednarek et al. | Jun 2006 | A1 |
20060178700 | Quinn | Aug 2006 | A1 |
20060224169 | Weisenburgh et al. | Oct 2006 | A1 |
20070010600 | Weitzner et al. | Jan 2007 | A1 |
20070010877 | Salahieh et al. | Jan 2007 | A1 |
20070016286 | Herrmann et al. | Jan 2007 | A1 |
20070021779 | Garvin et al. | Jan 2007 | A1 |
20070032807 | Ortiz et al. | Feb 2007 | A1 |
20070093857 | Rogers et al. | Apr 2007 | A1 |
20070093890 | Eliasen et al. | Apr 2007 | A1 |
20070191154 | Genereux et al. | Aug 2007 | A1 |
20070197858 | Goldfarb et al. | Aug 2007 | A1 |
20070198038 | Cohen et al. | Aug 2007 | A1 |
20070265700 | Eiiasen et al. | Nov 2007 | A1 |
20070282414 | Soltis et al. | Dec 2007 | A1 |
20070293943 | Quinn | Dec 2007 | A1 |
20070299424 | Cumming et al. | Dec 2007 | A1 |
20080039743 | Fox et al. | Feb 2008 | A1 |
20080039953 | Davis et al. | Feb 2008 | A1 |
20080065149 | Thielen et al. | Mar 2008 | A1 |
20080077144 | Crofford | Mar 2008 | A1 |
20080091169 | Heideman et al. | Apr 2008 | A1 |
20080140089 | Kogiso et al. | Jun 2008 | A1 |
20080147093 | Roskopf et al. | Jun 2008 | A1 |
20080147112 | Sheets et al. | Jun 2008 | A1 |
20080149001 | Hodges et al. | Jun 2008 | A1 |
20080167713 | Bolling | Jul 2008 | A1 |
20080177300 | Mas et al. | Jul 2008 | A1 |
20080208332 | Lamphere et al. | Aug 2008 | A1 |
20080221672 | Lamphere et al. | Sep 2008 | A1 |
20080255427 | Satake et al. | Oct 2008 | A1 |
20080281411 | Berreklouw | Nov 2008 | A1 |
20080287862 | Weitzner et al. | Nov 2008 | A1 |
20080294247 | Yang et al. | Nov 2008 | A1 |
20080312506 | Spivey et al. | Dec 2008 | A1 |
20080319455 | Harris et al. | Dec 2008 | A1 |
20090005663 | Goetz et al. | Jan 2009 | A1 |
20090024110 | Heideman et al. | Jan 2009 | A1 |
20090131880 | Speziali et al. | May 2009 | A1 |
20090156995 | Martin et al. | Jun 2009 | A1 |
20090163934 | Raschdorf, Jr. et al. | Jun 2009 | A1 |
20090166913 | Guo et al. | Jul 2009 | A1 |
20090177266 | Powell et al. | Jul 2009 | A1 |
20090216197 | Russo | Aug 2009 | A1 |
20090275902 | Heeps et al. | Nov 2009 | A1 |
20090287304 | Dahlgren et al. | Nov 2009 | A1 |
20100022823 | Goldfarb et al. | Jan 2010 | A1 |
20100057192 | Celermajer | Mar 2010 | A1 |
20100094317 | Goldfarb et al. | Apr 2010 | A1 |
20100106141 | Osypka et al. | Apr 2010 | A1 |
20100121434 | Paul et al. | May 2010 | A1 |
20100249497 | Peine et al. | Sep 2010 | A1 |
20100324595 | Linder et al. | Dec 2010 | A1 |
20110082538 | Dahlgren et al. | Apr 2011 | A1 |
20110137410 | Hacohen | Jun 2011 | A1 |
20110152779 | Panotopoulos | Jun 2011 | A1 |
20110245855 | Matsuoka et al. | Oct 2011 | A1 |
20110257723 | McNarnara | Oct 2011 | A1 |
20110295281 | Mizumoto et al. | Dec 2011 | A1 |
20120016312 | Brown et al. | Jan 2012 | A1 |
20120089125 | Scheibe et al. | Apr 2012 | A1 |
20120109160 | Martinez et al. | May 2012 | A1 |
20120116419 | Sigmon, Jr. | May 2012 | A1 |
20120209318 | Qadeer | Aug 2012 | A1 |
20120271237 | Andino | Oct 2012 | A1 |
20120316505 | Wright | Dec 2012 | A1 |
20130035759 | Gross et al. | Feb 2013 | A1 |
20130041314 | Dillon | Feb 2013 | A1 |
20130066341 | Ketai et al. | Mar 2013 | A1 |
20130066342 | Dell et al. | Mar 2013 | A1 |
20130072945 | Terada | Mar 2013 | A1 |
20130073034 | Wilson et al. | Mar 2013 | A1 |
20130190798 | Kapadia | Jul 2013 | A1 |
20130190861 | Chau et al. | Jul 2013 | A1 |
20130268069 | Zakai et al. | Oct 2013 | A1 |
20130304197 | Buchbinder et al. | Nov 2013 | A1 |
20130325110 | Khalil et al. | Dec 2013 | A1 |
20140031928 | Murphy et al. | Jan 2014 | A1 |
20140046433 | Kovalsky | Feb 2014 | A1 |
20140046434 | Rolando et al. | Feb 2014 | A1 |
20140052237 | Lane et al. | Feb 2014 | A1 |
20140058411 | Soutorine et al. | Feb 2014 | A1 |
20140067048 | Chau et al. | Mar 2014 | A1 |
20140067052 | Chau et al. | Mar 2014 | A1 |
20140094903 | Miller et al. | Apr 2014 | A1 |
20140135685 | Kabe et al. | May 2014 | A1 |
20140194975 | Quill et al. | Jul 2014 | A1 |
20140200662 | Eftel et al. | Jul 2014 | A1 |
20140207231 | Hacohen et al. | Jul 2014 | A1 |
20140236198 | Goldfarb et al. | Aug 2014 | A1 |
20140243968 | Padala | Aug 2014 | A1 |
20140251042 | Asselin et al. | Sep 2014 | A1 |
20140261099 | Lewis et al. | Sep 2014 | A1 |
20140277404 | Wilson et al. | Sep 2014 | A1 |
20140277411 | Bortlein et al. | Sep 2014 | A1 |
20140316428 | Golan | Oct 2014 | A1 |
20140324164 | Gross et al. | Oct 2014 | A1 |
20140330368 | Gloss et al. | Nov 2014 | A1 |
20140336751 | Kramer | Nov 2014 | A1 |
20140371843 | Wilson et al. | Dec 2014 | A1 |
20150005733 | Le et al. | Jan 2015 | A1 |
20150039084 | Levi et al. | Feb 2015 | A1 |
20150057704 | Takahashi | Feb 2015 | A1 |
20150094802 | Buchbinder et al. | Apr 2015 | A1 |
20150100116 | Mohl et al. | Apr 2015 | A1 |
20150105808 | Gordon et al. | Apr 2015 | A1 |
20150157268 | Winshtein et al. | Jun 2015 | A1 |
20150196390 | Ma et al. | Jul 2015 | A1 |
20150223793 | Goldfarb et al. | Aug 2015 | A1 |
20150230919 | Chau et al. | Aug 2015 | A1 |
20150238313 | Spence et al. | Aug 2015 | A1 |
20150257757 | Powers et al. | Sep 2015 | A1 |
20150257877 | Hernandez | Sep 2015 | A1 |
20150257883 | Basude et al. | Sep 2015 | A1 |
20150313592 | Coillard-Lavirotte et al. | Nov 2015 | A1 |
20150366666 | Khairkhahan et al. | Dec 2015 | A1 |
20160008131 | Christianson et al. | Jan 2016 | A1 |
20160022970 | Forcucci et al. | Jan 2016 | A1 |
20160106539 | Buchbinder et al. | Apr 2016 | A1 |
20160113762 | Clague et al. | Apr 2016 | A1 |
20160113764 | Sheahan et al. | Apr 2016 | A1 |
20160113766 | Ganesan et al. | Apr 2016 | A1 |
20160155987 | Yoo et al. | Jun 2016 | A1 |
20160174979 | Wei | Jun 2016 | A1 |
20160174981 | Fago et al. | Jun 2016 | A1 |
20160242906 | Morriss et al. | Aug 2016 | A1 |
20160287387 | Wei | Oct 2016 | A1 |
20160317290 | Chau et al. | Nov 2016 | A1 |
20160331523 | Chau et al. | Nov 2016 | A1 |
20160354082 | Oz et al. | Dec 2016 | A1 |
20160367332 | Shah et al. | Dec 2016 | A1 |
20170020521 | Krone et al. | Jan 2017 | A1 |
20170035561 | Rowe et al. | Feb 2017 | A1 |
20170035566 | Krone et al. | Feb 2017 | A1 |
20170042456 | Budiman | Feb 2017 | A1 |
20170042678 | Ganesan et al. | Feb 2017 | A1 |
20170049455 | Seguin | Feb 2017 | A1 |
20170100236 | Robertson et al. | Apr 2017 | A1 |
20170239048 | Goldfarb et al. | Aug 2017 | A1 |
20170252154 | Tubishevitz et al. | Sep 2017 | A1 |
20170281330 | Liljegren et al. | Oct 2017 | A1 |
20170348102 | Cousins et al. | Dec 2017 | A1 |
20180008311 | Shiroff et al. | Jan 2018 | A1 |
20180021044 | Miller et al. | Jan 2018 | A1 |
20180021129 | Peterson et al. | Jan 2018 | A1 |
20180021134 | McNiven et al. | Jan 2018 | A1 |
20180078271 | Thrasher, III | Mar 2018 | A1 |
20180126124 | Winston et al. | May 2018 | A1 |
20180146964 | Garcia et al. | May 2018 | A1 |
20180146966 | Hernandez et al. | May 2018 | A1 |
20180153552 | King et al. | Jun 2018 | A1 |
20180161159 | Lee et al. | Jun 2018 | A1 |
20180168803 | Pesce et al. | Jun 2018 | A1 |
20180221147 | Ganesan et al. | Aug 2018 | A1 |
20180235657 | Abunassar | Aug 2018 | A1 |
20180243086 | Barbarino et al. | Aug 2018 | A1 |
20180258665 | Reddy et al. | Sep 2018 | A1 |
20180263767 | Chau et al. | Sep 2018 | A1 |
20180296326 | Dixon et al. | Oct 2018 | A1 |
20180296327 | Dixon et al. | Oct 2018 | A1 |
20180296328 | Dixon et al. | Oct 2018 | A1 |
20180296329 | Dixon et al. | Oct 2018 | A1 |
20180296330 | Dixon et al. | Oct 2018 | A1 |
20180296331 | Dixon et al. | Oct 2018 | A1 |
20180296332 | Dixon et al. | Oct 2018 | A1 |
20180296333 | Dixon et al. | Oct 2018 | A1 |
20180296334 | Dixon et al. | Oct 2018 | A1 |
20180325661 | Delgado et al. | Nov 2018 | A1 |
20180325671 | Abunassar et al. | Nov 2018 | A1 |
20180333259 | Dibie | Nov 2018 | A1 |
20180353181 | Wei | Dec 2018 | A1 |
20190000613 | Delgado et al. | Jan 2019 | A1 |
20190000623 | Pan et al. | Jan 2019 | A1 |
20190008642 | Delgado et al. | Jan 2019 | A1 |
20190008643 | Delgado et al. | Jan 2019 | A1 |
20190015199 | Delgado et al. | Jan 2019 | A1 |
20190015200 | Delgado et al. | Jan 2019 | A1 |
20190015207 | Delgado et al. | Jan 2019 | A1 |
20190015208 | Delgado et al. | Jan 2019 | A1 |
20190021851 | Delgado et al. | Jan 2019 | A1 |
20190021852 | Delgado et al. | Jan 2019 | A1 |
20190029498 | Mankowski et al. | Jan 2019 | A1 |
20190029810 | Delgado et al. | Jan 2019 | A1 |
20190029813 | Delgado et al. | Jan 2019 | A1 |
20190030285 | Prabhu et al. | Jan 2019 | A1 |
20190060058 | Delgado et al. | Feb 2019 | A1 |
20190060059 | Delgado et al. | Feb 2019 | A1 |
20190060072 | Zeng | Feb 2019 | A1 |
20190060073 | Delgado et al. | Feb 2019 | A1 |
20190060074 | Delgado et al. | Feb 2019 | A1 |
20190060075 | Delgado et al. | Feb 2019 | A1 |
20190069991 | Metchik et al. | Mar 2019 | A1 |
20190069992 | Delgado et al. | Mar 2019 | A1 |
20190069993 | Delgado et al. | Mar 2019 | A1 |
20190105156 | He et al. | Apr 2019 | A1 |
20190111239 | Bolduc et al. | Apr 2019 | A1 |
20190142589 | Basude | May 2019 | A1 |
20190159782 | Kamaraj et al. | May 2019 | A1 |
20190167197 | Abunassar et al. | Jun 2019 | A1 |
20190209323 | Metchik et al. | Jul 2019 | A1 |
20190261995 | Goldfarb et al. | Aug 2019 | A1 |
20190261996 | Goldfarb et al. | Aug 2019 | A1 |
20190261997 | Goldfarb et al. | Aug 2019 | A1 |
20190314155 | Franklin et al. | Oct 2019 | A1 |
Number | Date | Country |
---|---|---|
1142351 | Feb 1997 | CN |
203355093 | Dec 2013 | CN |
204337479 | May 2015 | CN |
0098100 | Jan 1984 | EP |
2146050 | Feb 1973 | FR |
9711600 | Mar 1997 | FR |
8706474 | Nov 1987 | WO |
2017015632 | Jan 2017 | WO |
2018013856 | Jan 2018 | WO |
2018050200 | Mar 2018 | WO |
2018050203 | Mar 2018 | WO |
2018195015 | Oct 2018 | WO |
2018195201 | Oct 2018 | WO |
2018195215 | Oct 2018 | WO |
2019139904 | Jul 2019 | WO |
Entry |
---|
Al Zaibag et al., “Percutaneous Balloon Valvotomy in Tricuspid Stenosis”, British Heart Journal, vol. 57, No. 1, Jan. 1987. |
Al-Khaja et al., “Eleven Years' Experience with Carpentier-Edwards Biological Valves in Relation to Survival and Complications”, European Journal of Cardio-thoracic Surgery 3: pp. 305-311, 1989. |
Almagor et al., “Balloon Expandable Stent Implantation in Stenotic Right Heart Valved Conduits”, Journal of the American College of Cardiology, vol. 16, No. 5, pp. 1310-1314, Nov. 15, 1990. |
Andersen, et al., “Transluminal implantation of artificial heart valves. Description of a new expandable aortic valve and initial results with implantation by catheter technique in closed chest pigs.” European Heart Journal (1992), 13, 704-708. |
Andersen, H.R. “History of Percutaneous Aortic Valve Prosthesis,” Herz No. 34. pp. 343-346. 2009. |
Batista RJ et al., “Partial left ventriculectomy to treat end-stage heart disease”, Ann Thorac Surg., vol. 64, Issue—3, pp. 634-638, Sep. 1997. |
Beall AC Jr. et al., “Clinical experience with a dacron velour-covered teflon-disc mitral-valve prosthesis”, Ann Thorac Surg., vol. 5, Issue 5, pp. 402-410, May 1968. |
Benchimol et al., “Simultaneous Left Ventricular Echocardiography and Aortic Blood Velocity During Rapid Right Ventricular Pacing in Man”, The American Journal of the Medical Sciences, vol. 273, No. 1, pp. 55-62, 1977. |
Dake et al., “Transluminal Placement of Endovascular Stent-Grafts for the Treatment of Descending Thoracic Aortic Aneurysms”, The New England Journal of Medicine, vol. 331, No. 26, pp. 1729-1734, Dec. 29, 1994. |
Dotter et al., “Transluminal Treatment of Arteriosclerotic Obstruction: Description of a New Technic and a Preliminary Report of Its Application”, Circulation, vol. XXX, pp. 654-670, 1964. |
Fucci et al., “Improved results with mitral valve repair using new surgical techniques”, Eur J Cardiothorac Surg. 1995;Issue 9, vol. 11, pp. 621-626. |
Inoune, M.D., Kanji, et al., “Clinical Application of Transvenous Mitral Commissurotomy by a New Balloon Catheter,” The Journal of Thoracic and Cardiovascular Surgery 87:394-402, 1984. |
Kolata, Gina “Device that Opens Clogged Arteries Gets a Failing Grade in a New Study”, The New York Times, http://www.nytimes.com/1991/01/03/health/device-that-opens-clogged-arteries-gets-a-faili . . . , pp. 1-2, wrriten Jan. 3, 199, web page access Jul. 29, 2009. |
Lawrence, Jr., et al., “Percutaneous Endovascular Graft: Experimental Evaluation”, Cardiovascular Radiology 163, pp. 357-360, May 1987. |
Maisano F et al., ‘The edge-to-edge technique: a simplified method to correct mitral insufficiency’, Eur J Cardiothorac Surg., vol. 13, Issue—3, pp. 240-245, Mar. 1998. |
Pavcnik, M.D., Ph.D., Dusan, et al. “Development and Initial Experimental Evaluation of a Prosthetic Aortic Valve for Transcatheter Placement,” Cardiovascular Radiology 1992; 183:151-154. |
Porstmann et al., “Der Verschluß des Ductus Arteriosus Persistens Ohne Thorakotomie”, Thoraxchirurgie Vaskuläre Chirurgie, Band 15, Heft 2, Stuttgart, im Apr. 1967, pp. 199-203. |
Praz et al., “Compassionate use of the PASCAL transcatheter mitral valve repair system for patients with severe mitral regurgitation: a multicentre, prospective, observational, first-in-man study,” Lancet vol. 390, pp. 773-780, 2017. |
Rashkind et al., “Creation of an Atrial Septal Defect Without Thoracotomy: A Pallative Approach to Complete Transposition of the Great Arteries”, The Journal of the American Medical Association, vol. 196, No. 11, pp. 173-174, Jun. 13, 1956. |
Rashkind et al., “Historical Aspects of Interventional Cardiology: Past, Present, and Future”, Texas Heart Institute Journal, Interventional Cardiology, pp. 363-367. |
Reul RM et al., “Mitral valve reconstruction for mitral insufficiency”, Prog Cardiovasc Dis., vol. 39, Issue—6, May-Jun. 1997. |
Rosch, M.D., Josef, “The Birth, Early Years and Future of Interventional Radiology,” J Vasc Interv Radiol 2003; 14:841-853. |
Ross, D.N, “Aortic Valve Surgery”, Surgery of the Aortic Valves, Guy's Hospital, London, pp. 192-197. |
Sabbah et al., “Mechanical Factors in the Degeneration of Porcine Bioprosthetic Valves: An Overview”, Journal of Cardiac Surgery, vol. 4, No. 4, pp. 302-309, Dec. 1989. |
Selby et al., “Experience with New Retrieval Forceps for Foreign Body Removal in the Vascular, Urinary, and Biliary Systems”, Radiology: 176. pp. 535-538, 1990. |
Serruys et al., “Stenting of Coronary Arteries. Are we the Sorcerer's Apprentice?”, European Heart Journal, 10, 774-782, pp. 37-45, 1989. |
Sigwart, Ulrich, “An Overview of Intravascular Stents: Old and New,” Chapter 48, Textbook of Interventional Cardiology, 2nd Edition, W.B. Saunders Company, Philadelphia, PA, © 1994, 1990, pp. 803-815. |
Uchida et al., “Modifications of Gianturco Expandable Wire Stents”, Technical Note, American Roentgen Ray Society, pp. 1185-1187, May 1988. |
Umaña JP et al., Bow-tie' mitral valve repair: an adjuvant technique for ischemic mitral regurgitation, Ann Thorac Surg., vol. 66, Issue—6, pp. 1640-1646, Nov. 1998. |
Urban, Philip MD, “Coronary Artery Stenting”, Editions Medecine et Hygiene, Geneve, pp. 1-47, 1991. |
Watt et al., “Intravenous Adenosine in the Treatment of Supraventricular Tachycardia: A Dose-Ranging Study and Interaction with Dipyridamole”, Br. J. Clin. Pharmac. 21, pp. 227-230, 1986. |
Wheatley, David J., “Valve Prosthesis”, Rob & Smith's Operative Surgery, pp. 415-424, 1986. |
Number | Date | Country | |
---|---|---|---|
20180311474 A1 | Nov 2018 | US |
Number | Date | Country | |
---|---|---|---|
62491392 | Apr 2017 | US |